Researchers at Penn’s School of Dental Medicine are developing a clinical-grade chewing gum to combat herpes (HSV-1 and HSV-2) and bird flu. The gum, made from lablab beans containing an antiviral protein called FRIL, has shown promising results in neutralizing the viruses. Previous studies have demonstrated its effectiveness against H5N1 and H7N9, with scientists now exploring its potential use in bird feed to control bird flu outbreaks.
Seasonal influenza epidemics cause significant health challenges and economic losses, totaling over $11.2 billion annually in the US. Building on their previous work, which showed a similar approach reduced SARS-CoV-2 in COVID-19 patient saliva or swab samples by more than 95%, the researchers are now testing the gum’s efficacy against herpes and bird flu viruses. The study was supported by an NIH grant, further highlighting its potential as a novel treatment option.
Source: https://www.oralhealthgroup.com/clinical/dental-research/dental-researchers-are-developing-chewing-gum-to-neutralize-herpes-and-bird-flu-viruses-1003985613